GalNAcalpha1-3Gal, a new prognostic marker for cervical cancer. - Wikidata - awgldk - TriplyDB

GalNAcalpha1-3Gal, a new prognostic marker for cervical cancer.

GalNAcalpha1-3Gal, a new prognostic marker for cervical cancer.

http://www.wikidata.org/entity/Q37480147

about

Recognition of the Thomsen-Friedenreich Pancarcinoma Carbohydrate Antigen by a Lamprey Variable Lymphocyte Receptor Glycan microarrays for decoding the glycome.An array-based method to identify multivalent inhibitors.Sugar-binding proteins from fish: selection of high affinity "lambodies" that recognize biomedically relevant glycans.Competition between serum IgG, IgM, and IgA anti-glycan antibodies Enhanced epimerization of glycosylated amino acids during solid-phase peptide synthesis.Evaluation of human antibody responses to keyhole limpet hemocyanin on a carbohydrate microarray.Evaluation of riproximin binding properties reveals a novel mechanism for cellular targeting ABO blood type correlates with survival on prostate cancer vaccine therapy Specificity of serum anti-A(di) IgG antibodies from patients with gastrointestinal cancer.Micro ribonucleic acid-93 promotes oncogenesis of cervical cancer by targeting RAB11 family interacting protein 1.Gamma-secretase inhibitor DAPT suppresses glioblastoma growth via uncoupling of tumor vessel density from vessel function.Development and validation of a Luminex assay for detection of a predictive biomarker for PROSTVAC-VF therapy.Carbohydrate microarrays.

P2860

Q27678706-CE9FB438-FBB4-47CB-9549-DFEDC1167B65 Q31004845-1D4FFA23-0B89-4E34-A9D9-03E5A62636DF Q34073845-F74D90DD-AD59-4F1B-9538-F932ED0945EC Q34431854-C41B0044-5141-4958-B25B-5888A698D6CE Q35217313-7307728C-920B-4ED1-AD36-4B8059AB1CE4 Q35884182-81B9594C-225B-45AE-9C98-281D1C39FD67 Q36278684-2874EE55-1C00-4AB0-B963-2E4D1ECECF8A Q36332756-4CBD5436-7C75-4A05-9511-C3DCD4070790 Q36544831-AB388CFB-5891-40C8-ACD0-BAE5F24E95E9 Q38335166-179457D0-891D-4926-BBBD-DC2CAFDB6803 Q38765660-75A6CA4F-C88E-4A48-B0DF-DABD442F9A90 Q39307641-3CD49F6E-2BA8-4B93-8D03-6A941C3189F0 Q41238074-F9A0834A-4463-4E62-9DA5-C991EC81AC97 Q44302459-FF6012F4-54FC-4C5A-897F-B47E5D91C8E7

P2860

GalNAcalpha1-3Gal, a new prognostic marker for cervical cancer.

http://www.wikidata.org/entity/Q37480147

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

GalNAcalpha1-3Gal, a new prognostic marker for cervical cancer.

@en

GalNAcalpha1-3Gal, a new prognostic marker for cervical cancer.

@nl

type

label

GalNAcalpha1-3Gal, a new prognostic marker for cervical cancer.

@en

GalNAcalpha1-3Gal, a new prognostic marker for cervical cancer.

@nl

prefLabel

GalNAcalpha1-3Gal, a new prognostic marker for cervical cancer.

@en

GalNAcalpha1-3Gal, a new prognostic marker for cervical cancer.

@nl

P1433

Q37480147-20048712-021F-40C7-A64C-07A171095FC6

P1476

Q37480147-2EFF6CAD-CE0E-4662-9442-6C9C0B13728A

P2093

Q37480147-3C54E65A-1222-4FC9-BD1F-12438722CD42

Q37480147-79D211E2-A9CC-4775-B270-E19103F6036E

Q37480147-8C08DBCE-CF97-4B7C-8BD8-A09417B1433D

Q37480147-C6D383BF-A49D-48E7-83E6-BC8DDC8CADDD

Q37480147-EBBE6161-E932-4407-A6FF-5C5F8E0865F7

P2860

Q37480147-03054552-5FBB-402E-AFF0-41BD47A61046

Q37480147-1EDC4226-0052-4051-84B7-5FDD3F46F3F4

Q37480147-257CC4DE-3851-4334-B305-A41B487CC731

Q37480147-2B1210DE-0425-41E5-8AD7-0AC3BC10FE9B

Q37480147-3F718F9A-2B3E-41DC-A115-73699636E133

Q37480147-4AD10C02-E3AE-4C37-B6D8-80F947CE6D1D

Q37480147-5BED7C11-A3DD-45E4-BF7E-D0E374CFA95B

Q37480147-6031A712-5F8E-4C67-AC07-CE24B9F88B3C

Q37480147-63C69D7F-3842-4916-9D3C-FB853B568150

Q37480147-703FD886-3A90-4DC2-8952-61673DF3DAF1

P304

Q37480147-2992D0A1-4B1A-4043-9D46-012F75F58E33

P31

Q37480147-F7F4B64C-0287-43D9-A2E8-1AFCF47319B4

P356

Q37480147-FFA5AB95-DBC0-4523-B697-DACF0CB91F47

P433

Q37480147-29EB0DDA-DFBC-486B-826F-1CDDCFAAF3C9

P478

Q37480147-970D47C3-F329-4987-9EEB-D1B6692A23CF

P577

Q37480147-A57579FE-ECDA-41D3-AD29-712CC46FD529

P5875

Q37480147-4EE0B319-D595-4A96-929D-41C55C500BE5

P698

Q37480147-EAFCD640-4B92-4C7F-AD48-6B0BC37C7873

P921

Q37480147-2AD2EEAD-96A1-4659-BB0E-D0B9CDAD88EB

P932

Q37480147-8F47A351-D630-41EE-BDE2-FCE96B71B807

P356

P1433

International Journal of Cancer

P1476

GalNAcalpha1-3Gal, a new prognostic marker for cervical cancer.

@en

P2093

Donna O Butcher

http://www.w3.org/2001/XMLSchema#string

Jeffrey C Gildersleeve

http://www.w3.org/2001/XMLSchema#string

Miriam R Anver

http://www.w3.org/2001/XMLSchema#string

Qian Li

http://www.w3.org/2001/XMLSchema#string

Zhitao Li

http://www.w3.org/2001/XMLSchema#string

P2860

Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas

Cancer statistics, 2007

Cyclooxygenase-2 in cervical neoplasia: a review.

Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccines

Immunoreactive T and Tn antigens in malignancy: role in carcinoma diagnosis, prognosis, and immunotherapy.

The sweet and sour of cancer: glycans as novel therapeutic targets.

Sweet spots in functional glycomics.

Glycans in cancer and inflammation--potential for therapeutics and diagnostics.

Carbohydrate antigens: synthesis aspects and immunological applications in cancer.

Improved procedure for direct coupling of carbohydrates to proteins via reductive amination

P304

459-468

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.24716

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

126

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26654968

http://www.w3.org/2001/XMLSchema#string

P698

19585575

http://www.w3.org/2001/XMLSchema#string

P921

alpha-D-GalNAc-(1->3)-D-Gal

P932

2794947

http://www.w3.org/2001/XMLSchema#string